BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35475573)

  • 21. Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes.
    Diamanti K; Cavalli M; Pan G; Pereira MJ; Kumar C; Skrtic S; Grabherr M; Risérus U; Eriksson JW; Komorowski J; Wadelius C
    Sci Rep; 2019 Jul; 9(1):9653. PubMed ID: 31273253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes.
    Skovsø S; Damgaard J; Fels JJ; Olsen GS; Wolf XA; Rolin B; Holst JJ
    Int J Obes (Lond); 2015 Oct; 39(10):1531-8. PubMed ID: 26121961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance.
    Cree-Green M; Wiromrat P; Stuppy JJ; Thurston J; Bergman BC; Baumgartner AD; Bacon S; Scherzinger A; Pyle L; Nadeau KJ
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E186-E195. PubMed ID: 30562061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in Visceral and Subcutaneous Fat in Youth With Type 2 Diabetes in the TODAY Study.
    Dhaliwal R; Shepherd JA; El Ghormli L; Copeland KC; Geffner ME; Higgins J; Levitsky LL; Nadeau KJ; Weinstock RS; White NH;
    Diabetes Care; 2019 Aug; 42(8):1549-1559. PubMed ID: 31167889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.
    Barchetta I; Angelico F; Del Ben M; Di Martino M; Cimini FA; Bertoccini L; Polimeni L; Catalano C; Fraioli A; Del Vescovo R; Morini S; Baroni MG; Cavallo MG
    Clin Sci (Lond); 2016 Oct; 130(19):1753-62. PubMed ID: 27458255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered features of body composition in older adults with type 2 diabetes and prediabetes compared with matched controls.
    Bell KE; Paris MT; Avrutin E; Mourtzakis M
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1087-1099. PubMed ID: 35174664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial.
    Kjær TN; Ornstrup MJ; Poulsen MM; Stødkilde-Jørgensen H; Jessen N; Jørgensen JOL; Richelsen B; Pedersen SB
    J Clin Endocrinol Metab; 2017 May; 102(5):1642-1651. PubMed ID: 28182820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women.
    Direk K; Cecelja M; Astle W; Chowienczyk P; Spector TD; Falchi M; Andrew T
    BMC Cardiovasc Disord; 2013 Apr; 13():25. PubMed ID: 23552273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat.
    Lind L; Salihovic S; Risérus U; Kullberg J; Johansson L; Ahlström H; Eriksson JW; Oscarsson J
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e118-e129. PubMed ID: 33123723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreas Fat, an Early Marker of Metabolic Risk? A Magnetic Resonance Study of Chinese and Caucasian Women: TOFI_Asia Study.
    Sequeira IR; Yip WC; Lu LWW; Jiang Y; Murphy R; Plank LD; Cooper GJS; Peters CN; Lu J; Hollingsworth KG; Poppitt SD
    Front Physiol; 2022; 13():819606. PubMed ID: 35431998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic Lipid Deposition Is Associated With Insulin Resistance in Postmenopausal Women.
    Abildgaard J; Danielsen ER; Dorph E; Thomsen C; Juul A; Ewertsen C; Pedersen BK; Pedersen AT; Ploug T; Lindegaard B
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3394-3404. PubMed ID: 29889238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.
    Bello-Chavolla OY; Almeda-Valdes P; Gomez-Velasco D; Viveros-Ruiz T; Cruz-Bautista I; Romo-Romo A; Sánchez-Lázaro D; Meza-Oviedo D; Vargas-Vázquez A; Campos OA; Sevilla-González MDR; Martagón AJ; Hernández LM; Mehta R; Caballeros-Barragán CR; Aguilar-Salinas CA
    Eur J Endocrinol; 2018 May; 178(5):533-544. PubMed ID: 29535168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study.
    Porter SA; Pedley A; Massaro JM; Vasan RS; Hoffmann U; Fox CS
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):139-46. PubMed ID: 23162012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease.
    Nishimiya N; Tajima K; Imajo K; Kameda A; Yoshida E; Togashi Y; Aoki K; Inoue T; Nakajima A; Utsunomiya D; Terauchi Y
    Intern Med; 2021 Nov; 60(21):3391-3399. PubMed ID: 33994437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI.
    Cruz RJ; Dew MA; Myaskovsky L; Goodpaster B; Fox K; Fontes P; DiMartini A
    Transplantation; 2013 Feb; 95(4):617-22. PubMed ID: 23348896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.
    Kotronen A; Juurinen L; Hakkarainen A; Westerbacka J; Cornér A; Bergholm R; Yki-Järvinen H
    Diabetes Care; 2008 Jan; 31(1):165-9. PubMed ID: 17934148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged Japanese men with metabolic syndrome.
    Taira S; Shimabukuro M; Higa M; Yabiku K; Kozuka C; Ueda R; Sunagawa S; Ohshiro Y; Doi M; Nanba T; Kawamoto E; Nakayama Y; Nakamura H; Iha T; Nakachi S; Tomoyose T; Ikema T; Yamakawa K; Masuzaki H
    Intern Med; 2013; 52(14):1561-71. PubMed ID: 23857087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer.
    van Dijk DP; Bakens MJ; Coolsen MM; Rensen SS; van Dam RM; Bours MJ; Weijenberg MP; Dejong CH; Olde Damink SW
    J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):317-326. PubMed ID: 27897432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.